Home/Pipeline/Therapeutic Platform Standardization (Global Biotech)

Therapeutic Platform Standardization (Global Biotech)

Not Specified

DevelopmentActive

Key Facts

Indication
Not Specified
Phase
Development
Status
Active
Company

About Noxilizer

Noxilizer is a private company specializing in a novel nitrogen dioxide (NO2) gas sterilization platform for the life sciences industry. Its core innovation is an ultra-low temperature (10-30°C), surface-level sterilization process that addresses critical challenges with sensitive products like prefilled syringes, drug-device combinations, and sensors, where traditional methods like ethylene oxide (EO) or steam can damage products. The company operates through a dual business model of selling proprietary sterilization equipment and offering contract sterilization services, with validation projects underway with several biopharma clients for commercial products. Noxilizer's technology is positioned as a safer, faster, and more product-friendly alternative to established sterilization methods.

View full company profile

Therapeutic Areas

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved